View of Pharmacoeconomic Analysis of Cervical Cancer Cases Specific to Serotypes 16 and 18 Based on the Analysis of Protective Determinants and Risk Factors Based on Activity-Based Accounting in Morocco

Return to Article Details Pharmacoeconomic Analysis of Cervical Cancer Cases Specific to Serotypes 16 and 18 Based on the Analysis of Protective Determinants and Risk Factors Based on Activity-Based Accounting in Morocco Download Download PDF